Everything You Need to Know About the Suboxone Shot

A Suboxone shot is a medication used to treat opioid addiction and dependence. It is composed of two active ingredients: buprenorphine and naloxone. This helps to reduce withdrawal symptoms and cravings for opioids. Naloxone is an opioid antagonist, which means that it blocks the effects of opioids in the brain. This helps to prevent abuse and misuse of the medication. A Suboxone shot is administered by injection, and the dosage and frequency of administration are determined by a healthcare provider based on the patient’s individual needs.

The primary benefit of a Suboxone shot is its ability to treat opioid addiction and dependence. It can help patients manage withdrawal symptoms and cravings, reducing the risk of relapse and overdose. Additionally, Suboxone has a lower risk of abuse compared to other opioid medications, as the naloxone component helps to prevent misuse. Suboxone shots are also convenient for patients, as they only need to be administered once a month, reducing the need for daily medication management.

While Suboxone shots can be an effective treatment for opioid addiction, there are also risks and considerations to keep in mind. Common side effects of a Suboxone shot include nausea, headache, and constipation. Patients may also experience withdrawal symptoms if they stop taking the medication abruptly. Additionally, there is a potential for misuse or abuse of the medication, particularly if it is not administered and monitored properly by a healthcare provider. It is important for patients to discuss any concerns or questions with their provider and to follow the recommended dosage and administration guidelines.

Sublocade is a medication used to treat opioid addiction. It is a once-monthly injection that contains the active ingredient buprenorphine. This medication works by binding to the same receptors in the brain that opioids bind to, thereby reducing cravings and withdrawal symptoms. Sublocade was approved by the FDA in 2017 and is indicated for use in adults who have been receiving buprenorphine treatment for at least seven days.

Sublocade works by affecting the brain and nervous system. When the medication is injected, it slowly releases buprenorphine into the body over a month. This slow release helps to prevent withdrawal symptoms and cravings, making it easier for individuals to stay on track with their recovery. Compared to other medications used to treat opioid addiction, Sublocade has several advantages. For example, it only needs to be administered once a month, which can be more convenient for patients who have difficulty remembering to take their medication every day.

While Sublocade has many benefits, it is important to be aware of potential side effects and risks associated with this medication. Common side effects include injection site reactions, constipation, and headache. More serious side effects can include respiratory depression and liver damage. Patients should also be aware of the risks associated with mixing Sublocade with other medications or substances, as this can increase the risk of overdose or other complications. Patients need to discuss their medical history and any other medications they are taking with their healthcare provider before starting treatment with Sublocade.

Sublocade is a valuable tool in the fight against opioid addiction. Reducing cravings and withdrawal symptoms, can help individuals stay on track with their recovery and improve their chances of long-term success. However, it is important to be aware of the potential risks and side effects associated with this medication and to work closely with a healthcare provider to determine if Sublocade is the right choice for you. With the right support and treatment, individuals can overcome opioid addiction and reclaim their lives.

Most patients receive the Suboxone shot once every 30 days under medical supervision. This monthly injection provides a steady release of medication that keeps withdrawal symptoms and cravings under control throughout the month. Regular visits to your provider, such as Dr. Jonathan Hall, MD at Ascension Solutions Treatment, ensure each dose is administered safely, progress is monitored, and adjustments are made as needed to maintain stability and long-term recovery success.

The Suboxone shot, also known as extended-release buprenorphine, generally lasts around 30 days per injection. It delivers a steady dose of medication throughout the month, helping to control cravings and prevent withdrawal symptoms without the need for daily pills. This consistent delivery promotes stability, reduces relapse risks, and supports long-term recovery. For many patients, the monthly injection also provides convenience, privacy, and improved treatment adherence, allowing them to focus on rebuilding their lives while staying on track with their recovery plan under medical supervision.

At Ascension Solutions Treatment, Dr. Jonathan Hall, MD helps patients achieve long-term stability through the Suboxone shot—a monthly, extended-release medication designed to reduce cravings and prevent relapse. This innovative option eliminates the need for daily pills, providing consistent results and supporting patients who value discretion and convenience in their recovery journey.

Dr. Hall evaluates each patient’s medical history, treatment goals, and response to prior therapies before recommending the Suboxone shot. His patient-centered care ensures safety, comfort, and effective results throughout the process. Patients trust Dr. Hall for his ability to combine medical precision with compassionate follow-up care, helping them regain control and build confidence as they move toward sustained recovery.

Contact us today for more information or schedule an appointment. We have convenient locations to serve you at Peachtree Corners GA and Asheville NC. We serve patients from Peachtree Corners GA, Asheville NC, Swannanoa NC, Johns Creek GA, Woodfin NC, Biltmore Forest NC, Fairview NC, Roswell GA, Dunwoody GA, Pittsburg GA, Western North Carolina, and the surrounding areas.